Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Aurora Imaging Technology company develops and commercializes the Aurora® 1.5T Dedicated Breast MRI System, the only FDA-cleared MRI system engineered specifically for 3-D bilateral breast imaging. The system is designed to improve detection and diagnosis of breast cancer, particularly in women with dense breast tissue where standard mammography is less effective. The integrated platform offers both imaging and automated biopsy capabilities, enhancing clinical workflow and diagnostic accuracy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurora Imaging Technology.